Trial intelligence / Profile preview

Amitriptyline and Tamsulosin for urinary symptoms in patients with ureteral stent

IRCT2013041713043N1Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of amitriptyline and tamsulosin in nephrolithiasis and ureteral stent-related symptoms (USRS), sponsored by Bushehr University of Medical Sciences. Started May 2013; status: completed.

02

Drugs

amitriptylinetamsulosin
03

Conditions

nephrolithiasisureteral stent-related symptoms (USRS)

Beyond the preview

Go deeper on IRCT2013041713043N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013041713043N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call